novosteo

Fracture targeting therapeutic for bone healing
PI: Dr. Philip Low, Purdue University
Visit site


morphimmune

Hyper-targeted small molecules for reprogramming immune cells to treat disease
PI: Dr. Philip Low, Purdue University
Visit site


erisyon

Single molecule protein sequencing
PI: Dr. Edward Marcotte, University of Texas at Austin
Visit site


eradivir

Targeted therapeutics platform for Infectious diseases
PI: Dr. Philip Low, Purdue University


asalyxa logo

AsalyxaBio

ASX-100 neutrophil targeting platform to treat significant unmet medical needs
PI: Dr. Lola Eniola-Adefeso, University of Michigan
Visit site